The First Oncology-focused Venture Studio
A Moffitt Cancer Center initiative to accelerate the next wave of cancer innovation in partnership with Decimal.health
Join Our Launch – September 22, 2025
About AccelerONC
AccelerOnc Studio is the first venture studio in the United States solely dedicated to oncology innovation. This pioneering initiative is designed to translate the deep clinical, scientific, and technological expertise within health systems—starting with Moffitt—into impactful, scalable solutions for cancer patients worldwide.
AccelerOnc Studio will focus on identifying unmet clinical needs and commercializing intellectual property (IP) generated inside health systems and cancer centers, starting with Moffitt’s own IP. By fostering early-stage ventures rooted in real-world insights from frontline care and research, AccelerOnc aims to radically accelerate the path from innovation to impact in oncology.
AccelerOnc pairs Moffitt Cancer Center's cancer care leadership with Decimal.health's proven venture-building capabilities to turn ideas into impact.

Where Oncology Innovation Begins







Our Team
We are a global team of bold problem solvers accelerating oncology innovation to prevent and cure cancer. United by relentless resilience, excellence, and innovation, every member is an integral puzzle piece driving our vision forward.
